Christopher J Ryerson

Summary

Publications

  1. doi Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, Canada James Hogg Research Centre, St Paul s Hospital, Canada Electronic address
    Respir Med 108:203-10. 2014
  2. doi Prevalence and prognosis of unclassifiable interstitial lung disease
    Christopher J Ryerson
    Dept of Medicine, University of British Columbia, Vancouver, BC, Canada
    Eur Respir J 42:750-7. 2013
  3. doi Update on the diagnosis and classification of ILD
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Curr Opin Pulm Med 19:453-9. 2013
  4. doi Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Chest 144:234-40. 2013
  5. doi Dyspnea in idiopathic pulmonary fibrosis: a systematic review
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, USA
    J Pain Symptom Manage 43:771-82. 2012
  6. doi Depression is a common and chronic comorbidity in patients with interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA
    Respirology 17:525-32. 2012
  7. doi Cough predicts prognosis in idiopathic pulmonary fibrosis
    Christopher J Ryerson
    Department of Medicine, University of California San Francisco, San Francisco, California 94143, USA
    Respirology 16:969-75. 2011
  8. doi A multidimensional index and staging system for idiopathic pulmonary fibrosis
    Brett Ley
    Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Ann Intern Med 156:684-91. 2012
  9. doi Depression and functional status are strongly associated with dyspnea in interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, 505 Parnassus Ave, Box 0111, San Francisco, CA 94143, USA
    Chest 139:609-16. 2011
  10. pmc Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis
    Joyce S Lee
    Department of Medicine at University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Respir Med 107:249-55. 2013

Collaborators

Detail Information

Publications15

  1. doi Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, Canada James Hogg Research Centre, St Paul s Hospital, Canada Electronic address
    Respir Med 108:203-10. 2014
    ..Pulmonary rehabilitation improves outcomes in patients with interstitial lung disease (ILD), however it is unclear whether these effects are long lasting and which patients benefit most...
  2. doi Prevalence and prognosis of unclassifiable interstitial lung disease
    Christopher J Ryerson
    Dept of Medicine, University of British Columbia, Vancouver, BC, Canada
    Eur Respir J 42:750-7. 2013
    ..001) and a radiological fibrosis score (p = 0.02). Unclassifiable ILD represents approximately 10% of ILD cases and has a heterogeneous clinical course, which can be predicted using clinical and radiological variables. ..
  3. doi Update on the diagnosis and classification of ILD
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Curr Opin Pulm Med 19:453-9. 2013
    ..In addition, the strengths and limitations of the current approach to ILD diagnosis and management are discussed...
  4. doi Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Chest 144:234-40. 2013
    ..We sought to determine the prevalence, clinical features, and prognosis of CPFE in idiopathic pulmonary fibrosis (IPF), using a standardized and reproducible definition...
  5. doi Dyspnea in idiopathic pulmonary fibrosis: a systematic review
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California at San Francisco, San Francisco, CA, USA
    J Pain Symptom Manage 43:771-82. 2012
    ..Little is known about the treatment and correlates of dyspnea in idiopathic pulmonary fibrosis (IPF)...
  6. doi Depression is a common and chronic comorbidity in patients with interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA
    Respirology 17:525-32. 2012
    ..The aim of this study was to determine the prevalence of depression, characterize the association of depression with clinical variables and describe the natural history of depression in patients with ILD...
  7. doi Cough predicts prognosis in idiopathic pulmonary fibrosis
    Christopher J Ryerson
    Department of Medicine, University of California San Francisco, San Francisco, California 94143, USA
    Respirology 16:969-75. 2011
    ..The clinical associations and prognostic value of cough in IPF have not been adequately described. The objective of this study was to describe the characteristics and prognostic value of cough in IPF...
  8. doi A multidimensional index and staging system for idiopathic pulmonary fibrosis
    Brett Ley
    Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Ann Intern Med 156:684-91. 2012
    ..Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an overall poor prognosis. A simple-to-use staging system for IPF may improve prognostication, help guide management, and facilitate research...
  9. doi Depression and functional status are strongly associated with dyspnea in interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, 505 Parnassus Ave, Box 0111, San Francisco, CA 94143, USA
    Chest 139:609-16. 2011
    ..The aim of this study was to determine the relationship of dyspnea with clinical parameters, including depression and functional status, in patients with ILD...
  10. pmc Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis
    Joyce S Lee
    Department of Medicine at University of California, San Francisco, 505 Parnassus Avenue, Box 0111, San Francisco, CA 94143, USA
    Respir Med 107:249-55. 2013
    ..The objective of this study was to determine the frequency and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis...
  11. pmc Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
    Seung Ick Cha
    Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA 94143 0111, USA
    Respir Res 13:105. 2012
    ....
  12. doi Management of dyspnea in interstitial lung disease
    Christopher J Ryerson
    Department of Medicine, School of Medicine, University of California San Francisco, San Francisco, California, USA
    Curr Opin Support Palliat Care 4:69-75. 2010
    ..Dyspnea is the most common symptom in interstitial lung disease, yet little is known about its management. This review summarizes the available evidence for the treatment of dyspnea in interstitial lung disease...
  13. pmc Long-term survival in idiopathic pulmonary arterial hypertension associated with massive pulmonary artery dilation
    Vanja Petrovic
    Department of Medicine, University of British Columbia, Vancouver
    Can Respir J 18:e50-1. 2011
    ..Severe dilation of the main pulmonary arteries is present in both patients and may be related to long-term survival with idiopathic pulmonary arterial hypertension...
  14. pmc Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis
    Christopher J Ryerson
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Respir Res 11:12. 2010
    ..Previous meta-analyses of treatments for pulmonary arterial hypertension (PAH) have not shown mortality benefit from any individual class of medication...
  15. doi Hemodynamic stability after intraarterial injection of verapamil for cerebral vasospasm
    Alana M Flexman
    Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, CA, USA
    Anesth Analg 114:1292-6. 2012
    ....